Slovenia to launch generic version of Viagra

Jul 31, 2009

Krka, the biggest drugmaker in Slovenia, said Friday that its generic version of the impotency drug Viagra would be launched in September and priced 30 percent cheaper than the original.

"We'll launch it first in Slovenia and later on, when the patents expire in other countries (in 2012), we'll offer it in central, eastern and western Europe as well," Krka chief executive Joze Colaric told the Internet news site, Zurnal24.

Russia, in particular, was seen as an important market.

Krka's version of the erectile dysfunction drug would be marketed under the name "vizarsin" and, unlike the blue pills made by US drug giant , would be white in colour, Colaric said.

The European Medicines Agency EMEA authorised the marketing of Krka's generic version of on June 25.

(c) 2009 AFP

Explore further: Study finds information lacking from FDA on implanted medical devices

add to favorites email to friend print save as pdf

Related Stories

AIDS group objects to Viagra ads

Dec 14, 2006

An AIDS advocacy group in Los Angeles has asked the makers of Viagra to cease a marketing campaign that appears to promote the drug's recreational use.

European office withdraws Nexium patent

Dec 21, 2006

The European Patent Office, answering a generic drug maker's challenge, withdrew a patent on Britain-based AstraZeneca PLC's heartburn treatment, Nexium.

Viagra may aggravate sleep apnea

Sep 25, 2006

A study done in Brazil indicates a single dose of the erectile dysfunction drug Viagra may aggravate sleep apnea.

Cialis may have one-a-day version

Jun 13, 2006

U.S. drug giants Eli Lilly and Icos Corp. plan to seek regulatory approval to market a one-a-day version of their impotence-fighting drug Cialis.

Viagra sales don't meet expectations

May 20, 2007

While sales of erectile dysfunction drugs like Viagra have been steady since their release, their popularity has not met expectations, the Miami Herald said.

Recommended for you

Justice Department says Shire will pay $56.5M fine

Sep 24, 2014

The U.S. Department of Justice said Wednesday that Irish drugmaker Shire will pay $56.5 million to settle allegations it broke the law in promoting five different drugs, including its attention deficit disorder drugs Adderall ...

New FDA label bolsters safety case for Chantix

Sep 24, 2014

New government-approved labeling on Pfizer's drug Chantix suggests that the anti-smoking medication may not carry the risks of suicidal behavior that first earned it the Food and Drug Administration's strongest warning more ...

User comments : 0